We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

101 hedge funds and large institutions have $1.01B invested in Inhibrx, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

875% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 4

53% more funds holding

Funds holding: 66 → 101 (+35)

49% more capital invested

Capital invested by funds: $682M → $1.01B (+$333M)

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
101
Holders Change
+35
Holders Change %
+53.03%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
39
Increased
26
Reduced
24
Closed
4
Calls
$5.2M
Puts
–
Net Calls
+$5.2M
Net Calls Change
+$5.2M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1M
2
Capital World Investors
Capital World Investors
California
+$17.3M
3
State Street
State Street
Massachusetts
+$15.8M
4
CS
Candriam SCA
Luxembourg
+$15M
5
SI
Sofinnova Investments
California
+$14.7M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$11.5M
2
SFM
Sphera Funds Management
Israel
-$9.92M
3
IC
Ikarian Capital
Texas
-$5.6M
4
ACH
ArrowMark Colorado Holdings
Colorado
-$4.71M
5
SCM
Soleus Capital Management
Connecticut
-$3.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
26
Platinum Investment Management
Australia
$3.8M -$666K -16,654 -16%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.72M -$37.5K -938 -1%
Victory Capital Management
28
Victory Capital Management
Texas
$3.62M -$2.51M -62,687 -43%
Deutsche Bank
29
Deutsche Bank
Germany
$3.2M +$111K +2,769 +4%
N
30
Nuveen
North Carolina
$3.13M -$267K -6,676 -8%
SFM
31
Sphera Funds Management
Israel
$2.71M -$9.92M -248,146 -80%
JP Morgan Chase
32
JP Morgan Chase
New York
$2.68M +$1.48M +36,905 +151%
EGI
33
EAM Global Investors
California
$2.5M +$2.29M +57,263 New
Morgan Stanley
34
Morgan Stanley
New York
$2.46M +$2.12M +53,099 +1,625%
Walleye Capital
35
Walleye Capital
New York
$2.42M +$2.22M +55,533 New
Invesco
36
Invesco
Georgia
$2.28M -$306K -7,662 -13%
BG
37
Bellevue Group
Switzerland
$2.21M +$2.02M +50,500 New
Bank of America
38
Bank of America
North Carolina
$2.03M +$1.08M +27,089 +140%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$1.96M +$1.79M +44,796 New
PPA
40
Parametric Portfolio Associates
Washington
$1.76M +$104K +2,592 +7%
BC
41
Birchview Capital
Vermont
$1.75M +$1.6M +40,000 New
EI
42
EAM Investors
California
$1.72M +$1.58M +39,462 New
Rafferty Asset Management
43
Rafferty Asset Management
New York
$1.7M +$1.56M +38,913 New
Citigroup
44
Citigroup
New York
$1.62M +$1.35M +33,723 +997%
UBS Group
45
UBS Group
Switzerland
$1.61M +$1.48M +36,958 New
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$1.57M – – –
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.1M +$28.1K +702 +3%
LP
48
LMR Partners
United Kingdom
$1.09M +$1,000K +25,000 New
SCM
49
Silverarc Capital Management
Massachusetts
$1.08M +$986K +24,666 New
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$1.06M +$960K +24,000 New
1
2
3 4 5

INBX Hedge Fund Activity: Q4 2021 in Review

101 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q4 2021, worth a combined $1.01B — up 49% from $682M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new INBX positions and 4 closed out — a net gain of 35 holders — while 26 added to existing stakes and 24 trimmed.

The largest buyer was Vanguard Group, adding an estimated $21.1M. The largest seller was Wellington Management Group, cutting an estimated $11.5M.

  • 101 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q4 2021, up from 66 in Q3 2021.
  • Funds reported $1.01B of Inhibrx, Inc. Common Stock stock for Q4 2021, up 49% quarter-over-quarter.
  • 39 funds opened new Inhibrx, Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +35 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q4 2021 was Vanguard Group, an estimated $21.1M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q4 2021 was Wellington Management Group, an estimated $11.5M sold.

Based on aggregated 13F filings for Q4 2021.